Is Northern New England Clinical Oncology Society Inc Legit?

Northern New England Clinical Oncology Society Inc (NNECOS) demonstrates a generally healthy financial position with consistent asset growth over the past decade, reaching $1,854,686 in its latest filing. The organization has shown strong revenue generation, with the latest reported revenue at $906,641, and a significant surplus in 2023 ($842,585 revenue vs. $538,662 expenses). This consistent surplus contributes to its robust asset base. The organization's financial health appears stable, with no reported liabilities in most recent years, indicating good fiscal management. Regarding spending efficiency, NNECOS consistently reports 0% officer compensation across all available filings, which is a strong indicator of efficient use of funds and a commitment to minimizing administrative overhead related to executive pay. While a detailed breakdown of program, administrative, and fundraising expenses isn't provided in the summary data, the absence of officer compensation suggests a lean operational structure. The organization's ability to maintain a healthy surplus while growing its assets points to effective resource allocation. Transparency is high given the consistent filing of IRS Form 990s, with 13 filings available. The consistent reporting of 0% officer compensation is a key transparency point, indicating that executive leadership is either volunteer-based or compensated through other means not classified as officer compensation, which would require further investigation of the full 990 forms. The clear financial trends and lack of significant liabilities further enhance its transparency profile.